Beijing Beilu Pharmaceutical Co., Ltd is a market leader in the contrast agent industry in China. The company focuses on the research, production, and sales of contrast agent products, establishing a unique competitive advantage in this field. It has gained high visibility and market influence in the radiology industry and related fields. The company has expanded its business to include the development and production of other Chinese and Western medicines, such as antidiabetic drugs and psychiatric drugs. One of their new products, Jiawei Zhenxin Granules, is the only domestically approved pure Chinese medicine formulation for the treatment of generalized anxiety disorder. This medicine has precise efficacy, minimal side effects, and no dependency issues. It is expected to become a new source of profit growth for the company. The product has been granted a patent by the National Patent Office and was included in the Beijing Torch Program in October 2007.
Headquarters
7th Floor, Block A, Fenglan International Office Building, No. 32, Xizhimen North Street, Haidian District, Beijing
Beijing; Beijing;
Postal Code: 100082
Contact Details: Purchase the Beijing Beilu Pharmaceutical Co.,Ltd. report to view the information.
Website: http://www.beilu.com.cn
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service